TG Therapeutics Inc (TGTX)
13.99
+0.17
(+1.23%)
USD |
NASDAQ |
Apr 18, 16:00
14.31
+0.32
(+2.29%)
After-Hours: 20:00
TG Therapeutics Total Liabilities (Quarterly): 169.08M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 169.08M |
September 30, 2023 | 166.30M |
June 30, 2023 | 180.40M |
March 31, 2023 | 169.92M |
December 31, 2022 | 134.98M |
September 30, 2022 | 117.41M |
June 30, 2022 | 122.63M |
March 31, 2022 | 132.64M |
December 31, 2021 | 142.48M |
September 30, 2021 | 98.17M |
June 30, 2021 | 98.27M |
March 31, 2021 | 103.41M |
December 31, 2020 | 106.29M |
September 30, 2020 | 103.20M |
June 30, 2020 | 100.39M |
March 31, 2020 | 103.20M |
December 31, 2019 | 124.40M |
September 30, 2019 | 119.12M |
June 30, 2019 | 93.38M |
March 31, 2019 | 98.28M |
December 31, 2018 | 59.58M |
September 30, 2018 | 42.63M |
June 30, 2018 | 39.34M |
March 31, 2018 | 35.76M |
December 31, 2017 | 30.39M |
Date | Value |
---|---|
September 30, 2017 | 22.24M |
June 30, 2017 | 23.22M |
March 31, 2017 | 22.21M |
December 31, 2016 | 18.91M |
September 30, 2016 | 18.93M |
June 30, 2016 | 16.10M |
March 31, 2016 | 10.62M |
December 31, 2015 | 11.90M |
September 30, 2015 | 11.10M |
June 30, 2015 | 10.66M |
March 31, 2015 | 11.04M |
December 31, 2014 | 6.645M |
September 30, 2014 | 10.46M |
June 30, 2014 | 4.206M |
March 31, 2014 | 3.742M |
December 31, 2013 | 8.058M |
September 30, 2013 | 9.662M |
June 30, 2013 | 7.584M |
March 31, 2013 | 6.688M |
December 31, 2012 | 6.524M |
September 30, 2012 | 7.338M |
June 30, 2012 | 6.744M |
March 31, 2012 | 5.887M |
December 31, 2011 | 4.901M |
September 30, 2011 | 18.36M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
93.38M
Minimum
Jun 2019
180.40M
Maximum
Jun 2023
125.56M
Average
119.12M
Median
Sep 2019
Total Liabilities (Quarterly) Benchmarks
Amicus Therapeutics Inc | 617.71M |
Geron Corp | 146.13M |
Editas Medicine Inc | 150.06M |
G1 Therapeutics Inc | 86.15M |
Mersana Therapeutics Inc | 189.16M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 329.59M |
Shareholders Equity (Quarterly) | 160.50M |
Debt to Equity Ratio | 0.6238 |
Current Ratio | 5.918 |
Net Debt Paydown Yield | -0.23% |